Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115996 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Edward S Wickstead und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Dentistry, Faculty of Medicine & Dentistry, Queen Mary University of London, Blizard Institute, 4, Newark Street, London E1 2AT, UK. Hauptthemen laut MEDLINE: Lipopolysaccharides, Microglia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Westminster.
Abstract (Originalsprache)
Neuroinflammation driven primarily by microglia directly contributes to neuronal death in many neurodegenerative diseases. Classical anti-inflammatory approaches aim to suppress pro-inflammatory mediator production, but exploitation of inflammatory resolution may also be of benefit. A key driver of peripheral inflammatory resolution, formyl peptide receptor 2 (Fpr2), is expressed by microglia, but its therapeutic potential in neurodegeneration remains unclear. Here, we studied whether targeting of Fpr2 could reverse inflammatory microglial activation induced by the potent bacterial inflammogen lipopolysaccharide (LPS). Exposure of murine primary or immortalised BV2 microglia to LPS triggered pro-inflammatory phenotypic change and activation of ROS production, effects significantly attenuated by subsequent treatment with the Fpr2 agonist C43. Mechanistic studies showed C43 to act through p38 MAPK phosphorylation and reduction of LPS-induced NFκB nuclear translocation via prevention of IκBα degradation. Here, we provide proof-of-concept data highlighting Fpr2 as a potential target for control of microglial pro-inflammatory activity, suggesting that it may be a promising therapeutic target for the treatment of neuroinflammatory disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Dentistry, Faculty of Medicine & Dentistry, Queen Mary University of London, Blizard Institute, 4, Newark Street, London E1 2AT, UK.
- School of Life Sciences, College of Liberal Arts & Sciences, University of Westminster, 115, New Cavendish Street, London W1W 6UW, UK.
- Icahn School of Medicine at Mount Sinai, Department of Neurology, Simon Hess Medical and Science Building, New York, NY 10029, USA.
ORCID-Profile: Edward S Wickstead, Bradley T Elliott, Simon McArthur
Förderung
- University of Westminster
Zitieren
APA
Wickstead, E. S., Elliott, B. T., Pokorny, S., Biggs, C., Getting, S. J., & McArthur, S. (2023). Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115996
Vancouver
Wickstead ES, Elliott BT, Pokorny S, Biggs C, Getting SJ, McArthur S. Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115996
BibTeX
@article{Wickstead2023,
author = {Wickstead, Edward S and Elliott, Bradley T and Pokorny, Sarah and Biggs, Christopher and Getting, Stephen J and McArthur, Simon},
title = {Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115996}
}
EUVIMED